Kerry €23bn deal that got away

Acquisition would have doubled size of Iseq-listed company

Kerry has long wanted to expand its footprint in the better health/disease prevention space. Photograph: Dara Mac Dónaill

Kerry has long wanted to expand its footprint in the better health/disease prevention space. Photograph: Dara Mac Dónaill

 

At more than €23 billion, the acquisition of the nutrition and biosciences business of the US chemicals group DuPont would have been the largest deal ever carried out by an Iseq-listed company and would have seen Kerry Group double in size, overtaking CRH as the largest business on the Irish stock exchange. Presuming it had remained on the Irish market.

Kerry had been considered a shoo-in to acquire the DuPont unit but it appears to have been, as one insider put it, “pipped at the post” by New York-based International Flavors & Fragrances (IFF). DuPont said the deal valued the Nutrition and Biosciences (N&B) business at $26.2 billion based on IFF’s share price on Friday.

DuPont has been transforming itself following the break-up of DowDuPont, the chemical giant created in a 2017 megadeal.

The purchase would make “strategic sense, allowing IFF to offer a more complete product suite to a broader customer base”, according to Mark Astrachan, an analyst at Stifel, who said last week the deal would make it the largest global speciality ingredients company.

Footprint

Kerry has long wanted to expand its footprint in the better health/disease prevention space and DuPont was seemingly the perfect fit for its current suite of businesses. “ From a Kerry perspective, the announcement that two of its rivals will merge to become the clear industry leader will be a blow to the company,” said Goodbody analyst Jason Molins.

“Kerry’s share price will likely come under pressure as the perception was that Kerry was in pole position to merge with DuPont’s N&B business,” he said while noting that Kerry still had plenty of firepower for other acquisitions.

Kerry shares were down just under 3 per cent at €109.80 yesterday. Mega mergers are never easy to pull off, either financially or culturally. Just ask shareholders in Aryzta.

So it remains to be seen whether this was the one that got away or a lucky escape for Kerry.

The Irish Times Logo
Commenting on The Irish Times has changed. To comment you must now be an Irish Times subscriber.
SUBSCRIBE
GO BACK
Error Image
The account details entered are not currently associated with an Irish Times subscription. Please subscribe to sign in to comment.
Comment Sign In

Forgot password?
The Irish Times Logo
Thank you
You should receive instructions for resetting your password. When you have reset your password, you can Sign In.
The Irish Times Logo
Please choose a screen name. This name will appear beside any comments you post. Your screen name should follow the standards set out in our community standards.
Screen Name Selection

Hello

Please choose a screen name. This name will appear beside any comments you post. Your screen name should follow the standards set out in our community standards.

The Irish Times Logo
Commenting on The Irish Times has changed. To comment you must now be an Irish Times subscriber.
SUBSCRIBE
Forgot Password
Please enter your email address so we can send you a link to reset your password.

Sign In

Your Comments
We reserve the right to remove any content at any time from this Community, including without limitation if it violates the Community Standards. We ask that you report content that you in good faith believe violates the above rules by clicking the Flag link next to the offending comment or by filling out this form. New comments are only accepted for 3 days from the date of publication.